DV
Dividend Vision

ZYME — Zymeworks Inc.

Zymeworks Inc. (ZYME)

Total return is 93.2% over the past 9.3 years, 183.8 points behind SPY at 277.0%. Its deepest 1-year drawdown was 23.6%.

ZYME is a single-stock equity holding in Zymeworks Inc., a biotechnology company, rather than a diversified ETF fund. The holding does not currently pay dividends, resulting in no distribution rate or yield profile. This security appeals primarily to growth-oriented investors seeking exposure to the biotech sector rather than income-focused dividend investors.

ZYME key facts

Asset type
Stock
Asset class
Equity
Inception date
04/28/2017
Distribution frequency
None
Last close
$25.12
Market cap
$1,782,496,128
Average volume
332600.0
Beta
1.149
Payout ratio
0.0
Forward P/E
83.3333
EPS
$-2.02